01 Section
Eight hundred fifty milligrams belongs beside a meal
Eight hundred fifty milligrams belongs beside a meal, not beside a coffee on the way out the door. The US start for immediate-release metformin is 500 mg twice daily or 850 mg once daily, given with meals. This shelf locks the second of those. The body of the note may name 500 mg and 1000 mg. The search line stays on 850 mg with food.
Food lowers the peak. A single 850 mg tablet taken with a meal showed about a 40% lower mean Cmax, a 25% lower AUC, and a peak about 35 minutes later than the same tablet fasting. We still take it with food. The label is managing the gut, not chasing a taller peak. An empty-stomach 850 mg swallow is how people meet the diarrhea chapter on day one.
The day can later rise by 500 mg each week or by 850 mg every two weeks, on glucose and on tolerability, up to 2550 mg in split doses. Amounts above 2000 mg may sit better as three meals rather than two. Extended-release 500 mg or 750 mg is a different NDC and a different evening-meal habit. Do not crush an ER tablet because this page locked an IR 850 mg.
Dr. Ingrid Sørensen peer-passes the draft. Write [email protected] if a line is stale. We will not invent a start cost. A coupon board that lists 180 tablets is not a sixty-count month of 850 mg. Ask the window that can see your ZIP.
02 Section
The first letter is usually the gut
Loose stools in week two still count as a start letter, not as proof the tablet 'does not agree with you' forever. In a US trial of immediate-release metformin, diarrhea showed up in 53% on drug and 12% on placebo. Nausea or vomiting sat at 26% versus 8%. Flatulence, asthenia, indigestion, abdominal discomfort, and headache all cleared the greater-than-5% line and were more common than placebo. Diarrhea led to discontinuation in 6%.
Those percentages are a trial snapshot, not a promise about your second Tuesday. Most gut noise is loudest at the beginning. Taking the 850 mg with the plate, not an hour before it, is the first fix. Spreading a later rise across meals is the second. Switching the discussion to an extended-release evening tablet is a clinic move, not a solo swap in the kitchen.
If the diarrhea is bloody, if you cannot keep water down, or if you are losing weight you did not mean to lose, stop guessing and call. Persistent late gut change after months of peace is also a call, not a 'new normal.' The patient leaflet on some metformin tablets says to talk to the doctor if digestive symptoms continue. I agree with that dull sentence.
A greasy takeaway on the night you swallow the first 850 mg is an unforced error. I am not moralizing dinner. I am saying the tablet and the meal share a room. Give the start a plain plate for a fortnight before you decide the molecule is the villain. Then, if the gut is still the loudest thing in the house, take that report back. There are other first-line tools.
03 Section
When iodinated contrast pauses the 850 mg
| Pause the 850 mg? | Labelled trigger | Restart |
|---|---|---|
| Yes | eGFR 30-60 plus iodinated contrast | After eGFR at 48 hours, if stable |
| Yes | Liver disease, alcoholism, or heart failure plus contrast | Same 48-hour recheck |
| Yes | Intra-arterial iodinated contrast | Same 48-hour recheck |
| Ask | Surgery or a long fast | When the proceduralist and prescriber agree |
Iodinated dye and an 850 mg habit can share a calendar only if someone has read section 2.4. Stop metformin at the time of, or before, an iodinated contrast imaging procedure when eGFR is between 30 and 60, when there is a history of hepatic impairment, alcoholism, or heart failure, or when the dye will be intra-arterial. Re-evaluate eGFR 48 hours later. Restart only if renal function is stable.
That is the US tablet label. It is narrower than a folk rule that says 'everyone stops metformin for every CT.' It is also stricter than a folk rule that says 'healthy kidneys never pause.' I follow the printed conditions. If your eGFR is 72, you have no liver story, no heart failure, no alcohol-use disorder, and the dye is intravenous, the labelled pause may not apply. If any of those flags are present, the pause does.
The dye does not 'react' with metformin in a test tube. The sequence is kidney injury from contrast, then metformin that cannot leave, then acidosis in a person who was already on the edge. That is why the restart waits on a number, not on a feeling that the scan 'went fine.' Forty-eight hours is the labelled recheck, not a superstition.
Tell the imaging desk you take metformin 850 mg. Tell them the last eGFR if you have it. Tell the person who wrote the tablet that a scan is booked. Surgery and other procedures that shut down food and drink are a separate labelled pause. Do not borrow a neighbour's CT story. Their filtration is not yours.
04 Section
Filtration rate is the door, not a footnote
The 850 mg start, before the first plate
Estimated filtration rate is the door before the first 850 mg swallow. Obtain an eGFR before initiation. Do not use the tablet if eGFR is below 30 mL/min/1.73 m². That is a contraindication, not a soft preference. Initiation is not recommended between 30 and 45. If eGFR later falls below 45, weigh continuing. If it falls below 30, stop.
Metformin is cleared by the kidney. The boxed warning on lactic acidosis exists because accumulation plus a second hit - hypoxia, liver failure, a binge, a dye study, shock - can write a rare, deadly acidosis. Postmarketing cases included death, hypothermia, hypotension, and resistant bradyarrhythmias. Lactate was typically above 5 mmol/L. Metformin levels were generally above 5 mcg/mL. Onset can look like malaise, muscle ache, belly pain, sleepiness, or breath trouble.
Age 65 or older is a named risk band because filtration, liver, and heart are more often already impaired. Check eGFR more often in that group. Clinical or laboratory liver disease is a reason to avoid the tablet. Acute heart-failure hypoperfusion, sepsis, and other hypoxic states are reasons to stop it. Mitochondrial diseases such as MELAS are on the same avoid list.
A 'normal creatinine' on a paper printout is not an eGFR. Ask for the estimated rate. A smaller older body can look reassuring on creatinine and still sit at 38. I will not start 850 mg on a vibe. I will start it on a number, with a meal, and with a plan for the first gut fortnight.
05 Section
This start does not drop sugar the way a secretagogue does
Insulin and sulfonylureas can drop glucose on their own. Metformin raises that risk when it is stacked with them. The labelled move is to consider a lower insulin or secretagogue amount when the combination starts. Used alone, metformin is not the tablet I reach for when I want a fast, deep glucose fall. People who skip lunch on 850 mg and wait for a hypo are waiting for a story the monotherapy file rarely writes.
What the tablet does write is a slower hepatic glucose output and a better use of the insulin you already make. That is why it is a first-line type 2 tablet and why it does not replace food. If a low does happen on metformin alone, look for another cause: a missed meal plus another drug, an illness, an alcohol binge, or a dose that was not the 850 mg start you thought it was.
Weight change, when it comes, is usually modest and is not the reason I start the tablet. I start it for glucose and for a long safety record when the kidneys allow it. A social-media 'erases appetite' claim is not a labelled endpoint. If appetite falls because the gut is unhappy, that is a tolerability problem, not a feature.
A1C and a fasting glucose are how we judge a start, not a single home number on day three. Give the 850 mg and the plate a few weeks, then look at the trend. If the prescriber is already planning a rise at two weeks, that rise is 850 mg every two weeks on the label, or 500 mg weekly, not a jump to 2550 mg because a forum said so.
06 Section
Start cost is asked at a counter, not invented here
What I will not print as a price
- Ask the window to price the 850 mg count on the script, not a 180-count board.
- IR 850 mg and an ER 500 mg or 750 mg are different NDCs.
- Brand Glucophage and generic metformin 850 mg share the molecule, not the invoice.
- Bellis does not dispense and does not invent a dollar.
Sixty tablets of the 850 mg strength is a common month if the later plan is twice daily. A once-daily 850 mg start is thirty. Coupon boards often print a 180-count. Those are different invoices. I will not type a dollar. Ask the window to price the count on the script. Brand Glucophage and generic metformin 850 mg are the same biguanide in different packaging.
Extended-release 500 mg or 750 mg is another NDC. Do not let a cheap ER quote stand in for an IR 850 mg start, or the reverse. Membership warehouses, grocery pharmacies, and mail-order desks will not match each other, and they will not match last month. The metformin medicine note is where a dated cash window belongs if we publish one. This guide will not fake a neighbour's receipt.
Cost is a poor reason to skip the meal that makes the 850 mg tolerable, or to split a film-coated tablet you were not told to split. If thirty tablets feel like a lot of money for a start, say that. A 500 mg twice-daily start is the other labelled door and sometimes a gentler gut. That is a prescriber choice, not a coupon hack.
Keep the bottle labelled. An 850 mg piece is easy to mix with other white tablets in a weekly box. The person who later asks 'did you take it with food?' should be able to read the strength. Dull. Useful.
07 Section
Sick days, a binge, and a later B12 check
Heavy drinking and a viral week do not belong next to a fresh 850 mg start. Excessive alcohol is a named lactic acidosis risk. So is a hypoxic illness. If you cannot eat, if you are pouring, or if you are in hospital with a chest infection, the tablet is a conversation, not a habit you keep because the box says 'daily.' Some of us use a sick-day pause. That pause is drawn in clinic, not invented on a walk.
In 29-week trials, about 7% of people with a previously normal B12 drifted to a subnormal level. The mechanism looks like interference with the B12-intrinsic-factor complex. Anemia can follow. It often reverses if the tablet stops or if B12 is replaced. The labelled watch is hematologic parameters each year and a B12 at two- to three-year intervals, sooner if the person was already low on B12 or calcium.
Carbonic-anhydrase inhibitors such as topiramate add an acidosis risk. Drugs that block renal metformin transport can raise exposure. I will not turn this paragraph into a full interaction chapter. I will say: bring the whole list. A new migraine tablet is not trivial next to metformin.
Taste change and a metallic mouth show up on some lists. They are annoying and they are not lactic acidosis. The acidosis picture is malaise, muscle ache, belly pain, sleepiness, or breathing that feels wrong. That picture goes to a hospital, not to a wait-and-see night. Hemodialysis is the labelled rescue when the diagnosis is made.
08 Section
Keep the plate, the eGFR, and the pause on the same card
Keep the plate and the pause in the same pocket as the 850 mg bottle. Swallow with food. Do not start if the eGFR is in the forbidden band. Hold the tablet around iodinated contrast when the labelled flags are present, then restart only after a 48-hour kidney number. The gut will probably complain. That complaint is common. The boxed warning is rare and is not a gut complaint.
Dr. Ingrid Sørensen signs this daylight note. The longer file lives on the metformin page. Public-language dosing also sits on MedlinePlus for metformin. Write [email protected] if a line here has gone stale. Do not write for a prescription. The shelf does not fill bottles.